4
Changes in Ownership
Vanda Pharmaceuticals Inc. Filed Acc 0001209191-19-047610
Director sold 15,000 shares at $14.85 ($222,750)
- Director acquired 15,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DUGAN RICHARD W Director | 2019-08-26 | Option exercise | +15,000 | $14.78 | $221,700 | 50,770 | D: show line 1 in the form |
| DUGAN RICHARD W Director | 2019-08-26 | Sale | −15,000 | $14.85 | $222,750 | 35,770 | D: show line 2 in the form |
| Open-market sales · 15,000 sh · avg $14.85 · $222,750 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| DUGAN RICHARD W Director | 2019-08-26 | Option exercise · Nonstatutory Stock Option (Right to Buy) | −15,000 | 0 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…